Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes.
Open Access
- 1 February 1993
- journal article
- abstracts
- Published by Elsevier
- Vol. 268 (5) , 3734-3738
- https://doi.org/10.1016/s0021-9258(18)53755-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationNature, 1992
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurinNature, 1992
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Cell Cycle Control of DNA Replication by a Homologue from Human Cells of the p34
cdc2
Protein KinaseScience, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970